Oxytocin 2MG

Oxytocin is a cyclic nonapeptide neurohormone synthesized in the hypothalamic paraventricular and supraoptic nuclei and released from posterior pituitary terminals. In research contexts, Oxytocin 2 mg formulations are employed to study neuroendocrine modulation, social cognition, and smooth-muscle contractility through precise peptide receptor signaling.

Target: Oxytocin receptor (OXTR), a G-protein–coupled receptor (GPCR) distributed in uterine, mammary, and central neural tissues.
Mode: Ligand binding activates phospholipase C → IP₃/DAG cascade → intracellular Ca²⁺ release, stimulating smooth-muscle contraction and modulating neuronal firing patterns in limbic and brain-stem circuits.
Central Activity: OXTR expression within amygdala, nucleus accumbens, and prefrontal cortex underlies ongoing research into empathy, bonding, stress regulation, and autonomic control.

Behavioral neuroscience and social-affiliation studies • Stress-axis modulation (HPA feedback) • Smooth-muscle physiology and uterotonic assays • Lactation and endocrine-release models • Cardiovascular and autonomic research involving oxytocinergic pathways.

Revitalized Health peptides are manufactured under cGMP-aligned conditions with pharmaceutical-grade reagents. Each Oxytocin 2 mg lot is confirmed at ≥99 % purity by HPLC and structurally verified via LC-MS/MS. Lots are evaluated for appearance, solubility, and microbial/endotoxin compliance to research-grade standards. Batch-specific Certificates of Analysis document analytical data and traceability.

Store lyophilized vials at 2–8 °C, protected from light and moisture. Following reconstitution with bacteriostatic water, maintain at 2–8 °C and utilize within 20 days. Avoid repeated freeze–thaw cycles to preserve conformational integrity and receptor-binding fidelity.

For laboratory research use only. Not intended for human consumption, therapeutic, or diagnostic application. Supplied exclusively to qualified professionals conducting controlled scientific investigations.

Identity: Oxytocin, a cyclic nonapeptide (Cys–Tyr–Ile–Gln–Asn–Cys–Pro–Leu–Gly-NH₂) with intramolecular disulfide bridge; endogenous hypothalamic neurohormone.
Mode: Binds the oxytocin receptor (OXTR), a G_q/11-coupled GPCR → PLCβ activation → IP₃/DAG → Ca²⁺ mobilization and downstream kinase cascades. Peripheral: uterotonic effects on myometrium and milk ejection via myoepithelial contraction. CNS (research): modulatory effects on amygdala reactivity, social salience, trust/affiliation paradigms, and stress-axis signaling; outcomes vary by dose, timing, sex, and context.
Analytics: Identity/purity by HPLC/LC-MS; peptide content & counter-ion profile; sterility/endotoxin where applicable; stability (accelerated/real-time). PD readouts (research): eye-tracking and emotion recognition tasks, RMET/Trust tasks, fMRI (amygdala/insula connectivity), HRV/cortisol, nasal tolerability scales. Cautions: avoid pregnancy/lactation use without clinical supervision due to uterotonic and lactation effects; large parenteral doses historically linked to fluid retention/hyponatremia risk—dose/formulation discipline required.